Castle Biosciences Inc Stock News
$26.65
0.69%
yesterday
Nasdaq,
Dec 30, 09:48 pm CET
Castle Biosciences Inc Stock News
Neutral
Business Wire
●
7 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle today provided an update on its test currently in development for use in patients diagnosed with moderate-to-severe atopic dermatitis.
Neutral
Business Wire
●
11 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle's Compensation Committee of its Board of Directors granted restricted stock units (RSUs) as inducement material to new employees.
Neutral
Business Wire
●
18 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Meta-analysis concludes DecisionDx-Melanoma provides improved risk stratification over staging alone to inform personalized management of melanoma.
Neutral
Business Wire
●
about one month ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle's executive management will present a company overview at the Piper Sandler 36th Annual Healthcare Conference on Dec. 4, 2024, at 10:50 am ET.
Neutral
Business Wire
●
about one month ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle has been named a Houston Top Workplace by the Houston Chronicle for the 4th straight year and has earned 3 national Culture Excellence awards.
Neutral
Business Wire
●
about 2 months ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #ASDP24--Castle will share new data highlighting the clinical performance of its DecisionDx-Melanoma and MyPath Melanoma tests at the ASDP 61st Annual Meeting.
Neutral
Business Wire
●
about 2 months ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle's TissueCypher Barrett's Esophagus test surpassed 25,000 test reports delivered since the Company acquired the test at the end of 2021.
Neutral
Business Wire
●
about 2 months ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--New data demonstrates Castle's DecisionDx-Melanoma test can accurately identify patients with a low risk of metastasis who can safely forgo SLNB.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
